This roundtable webinar will introduce hemodiafiltration and examine whether it should become the gold standard for dialysis in the United States. To help address this question, the results of the CONVINCE Trial in the context of the totality of evidence and the key factors influencing efficacy of a hemodiafiltration prescription will be discussed.
Event Date: 10/28/2024

